Back to top
more

MEDIFAST (MED)

(Real Time Quote from BATS)

$13.26 USD

13.26
72,675

+0.23 (1.77%)

Updated Aug 15, 2025 11:48 AM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value F Growth F Momentum F VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 27% (180 out of 246)

Industry: Food - Miscellaneous

Zacks News

Zacks Equity Research

Kraft Heinz's (KHC) Hemmer Buyout to Grow Taste Elevation Platform

Kraft Heinz (KHC) will acquire the Brazil-based condiments and sauces company, Hemmer. The move will expand the company's footprint across emerging markets.

Zacks Equity Research

Sysco's (SYY) Cutting Edge Solutions Products to Fuel Growth

Sysco (SYY) unveils eight innovative concepts through the company's Cutting Edge Solutions platform, which is likely to enhance its customers' experience.

Zacks Equity Research

General Mills' (GIS) Q1 Earnings Top Estimates, Sales Up Y/Y

General Mills' (GIS) first-quarter fiscal 2022 results reflect higher sales driven by solid performance across most segments. However, earnings decline year over year.

Zacks Equity Research

B&G Foods (BGS) Hurt by Cost Inflation, Down 10% in 6 Months

B&G Foods (BGS) is encountering coronavirus-related costs for the past few quarters. Also, higher cost inflation is affecting gross margin performance.

Zacks Equity Research

Medifast (MED) Worth Relishing on OPTAVIA Strength, Growth Plans

Medifast (MED) has been benefiting from its OPTAVIA lifestyle solution and coaching support system as well as focus on capacity expansion and technological advancements.

Zacks Equity Research

Helen of Troy (HELE) Up on Solid Leadership Brands & Online Sales

Helen of Troy (HELE) is focused on making solid investments in the Leadership Brands. Also, the company is gaining from its consistent online sales.

Zacks Equity Research

Kellogg (K) Gains on Emerging Market Strength, Costs Flare Up

Kellogg (K) is gaining on its solid emerging market performance as well as brand strength. However, the company expects elevated cost inflation in the second half of 2021.

Zacks Equity Research

Flowers Foods' (FLO) Core Strategies Aid, Costs Flare Up

Flowers Foods (FLO) is on track with its core priorities and pricing efforts. However, the company expects to see significant cost inflation in the near term.

Zacks Equity Research

Philip Morris (PM) Secures More than 74% Stake in Vectura

Philip Morris (PM) secures more than 74% of Vectura's shares to become a majority stakeholder. The company expects to amplify growth in its Beyond Nicotine strategy via this move.

Zacks Equity Research

Philip Morris (PM) Buys Fertin Pharma, Announces Dividend Hike

Philip Morris (PM) buys Fertin Pharma to attain its target of becoming a majority smoke-free company by 2025. The company also raises its quarterly dividend.

Zacks Equity Research

Has MEDIFAST INC (MED) Outpaced Other Consumer Staples Stocks This Year?

Is (MED) Outperforming Other Consumer Staples Stocks This Year?

Zacks Equity Research

Pilgrim's Pride (PPC) Looks Solid: Up More Than 20% in 3 Months

Pilgrim's Pride's (PPC) focus on key customers is a pathway for refining portfolio and building competitive advantages. Solid performance across all regions in the second quarter bodes well.

Sanghamitra Saha headshot

5 Top-Ranked Stocks Backed by DuPont Technique for Solid Returns

Have more faith in DuPont analysis than simple ROE calculation? Bet on these five stocks.

Zacks Equity Research

Hershey (HSY) Gains on Prudent Acquisitions & Brand Strength

Hershey (HSY) makes several strategic acquisitions to enhance its brand portfolio. The company's solid pricing initiatives are also yielding.

Zacks Equity Research

Service Corporation (SCI) Looks Solid: Up More Than 15% in 3 Months

Service Corporation (SCI) is in a robust shape, thanks to the stellar Cemetery segment revenues as well as stringent cost control.

Zacks Equity Research

Helen of Troy (HELE) Rewards Shareholders, Unveils New Buybacks

Helen of Troy (HELE) approves repurchase of shares worth $500 million to return capital not otherwise deployed toward strategic buyouts or core business growth.

Zacks Equity Research

Kraft Heinz (KHC) Brings Agility to Scale, Operating Model Solid

Kraft Heinz (KHC) is benefiting from incorporating agility to its scale along with strength in the operating model. Management expects to post adjusted EBITDA of more than $6.1 billion in 2021.

Zacks Equity Research

Lamb Weston (LW) Troubled by High Costs, Supply-Chain Woes

Lamb Weston (LW) is battling input and transportation cost inflation along with supply-chain hiccups. The company's Retail segment is seeing tough sales comparisons with the year-ago period.

Zacks Equity Research

The J.M. Smucker (SJM) Hurt by High Costs, Supply-Chain Woes

The J.M. Smucker (SJM) is bearing the brunt of commodity cost inflation and supply-chain volatility. Management trims earnings view during its last quarterly release.

Zacks Equity Research

Conagra (CAG) Troubled by Escalated Costs & Divestitures

Conagra Brands (CAG) expects cost inflation of 9% in fiscal 2022. The company is also seeing tough comparisons with the year-ago period's initial pandemic-led demand spike.

Zacks Equity Research

McCormick (MKC) Benefits From Prudent Buyouts & Innovations

McCormick (MKC) expands its presence through acquisitions to boost portfolio. The company's focus on cost savings bodes well.

Zacks Equity Research

Kraft Heinz's (KHC) Operating Model Solid, Costs Inflated

Strength in Kraft Heinz's (KHC) operating model, which incorporates five key elements, bodes well. However, cost inflation is a persistent challenge for the company.

Zacks Equity Research

Zacks.com featured highlights include: Delta Apparel, Medifast and Service Corp

Zacks.com featured highlights include: Delta Apparel, Medifast and Service Corp

Zacks Equity Research

General Mills (GIS) Poised on Key Priorities, Costs Inflated

General Mills' (GIS) core priorities, focus on the Accelerate strategy and saving initiatives have been aiding the company amid an inflated cost scenario.

Zacks Equity Research

Why Is Medifast (MED) Down 10.8% Since Last Earnings Report?

Medifast (MED) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.